ASP Isotopes (NASDAQ:ASPI) Shares Gap Down – Here’s Why

ASP Isotopes Inc. (NASDAQ:ASPI)’s share price gapped down before the market opened on Thursday . The stock had previously closed at $4.58, but opened at $4.33. ASP Isotopes shares last traded at $4.11, with a volume of 2,020,364 shares.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Canaccord Genuity Group restated a “buy” rating and issued a $11.00 price objective on shares of ASP Isotopes in a research report on Tuesday, April 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research note on Wednesday, June 24th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $13.00.

ASP Isotopes Price Performance

The stock’s 50 day simple moving average is $6.14 and its two-hundred day simple moving average is $5.82. The firm has a market capitalization of $488.49 million, a PE ratio of -1.87 and a beta of 3.51. The company has a debt-to-equity ratio of 0.69, a quick ratio of 4.37 and a current ratio of 4.39.

ASP Isotopes (NASDAQ:ASPI) last posted its earnings results on Wednesday, May 20th. The company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.28) by $0.06. ASP Isotopes had a negative net margin of 644.40% and a negative return on equity of 112.46%. The company had revenue of $8.36 million for the quarter, compared to analyst estimates of $3.68 million.

Insider Buying and Selling

In other news, COO Robert Ainscow sold 8,438 shares of the stock in a transaction that occurred on Monday, June 8th. The stock was sold at an average price of $7.00, for a total value of $59,066.00. Following the completion of the sale, the chief operating officer directly owned 2,281,879 shares of the company’s stock, valued at approximately $15,973,153. This represents a 0.37% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Todd Wider sold 50,000 shares of the firm’s stock in a transaction dated Monday, June 29th. The stock was sold at an average price of $6.25, for a total value of $312,500.00. Following the transaction, the director directly owned 722,247 shares in the company, valued at approximately $4,514,043.75. This represents a 6.47% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 279,079 shares of company stock worth $2,049,208 over the last three months. 14.40% of the stock is owned by insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Mercer Global Advisors Inc. ADV increased its holdings in ASP Isotopes by 8.3% in the third quarter. Mercer Global Advisors Inc. ADV now owns 21,056 shares of the company’s stock worth $203,000 after buying an additional 1,622 shares during the last quarter. The Manufacturers Life Insurance Company raised its holdings in ASP Isotopes by 9.9% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 20,840 shares of the company’s stock worth $153,000 after acquiring an additional 1,878 shares during the period. Legal & General Group Plc increased its stake in shares of ASP Isotopes by 30.4% in the third quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock worth $81,000 after purchasing an additional 1,953 shares during the period. BNP Paribas Financial Markets increased its position in ASP Isotopes by 84.9% in the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after buying an additional 2,548 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in ASP Isotopes by 9.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 31,613 shares of the company’s stock worth $148,000 after acquiring an additional 2,709 shares during the period. Hedge funds and other institutional investors own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.